Trial Profile
A Phase I Pazufloxacin Mesilate Ear Drops in Patients With Chronic Suppurative Otitis Media
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Aug 2020
Price :
$35
*
At a glance
- Drugs Pazufloxacin (Primary)
- Indications Otitis media; Tympanic membrane perforation
- Focus Adverse reactions
- Sponsors Lee's Pharmaceutical
- 22 Sep 2018 New trial record